NASDAQ:NCTYThe9 Stock Price, Forecast & News

The9's stock was trading at $0.6387 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NCTY stock has increased by 24.3% and is now trading at $0.7942. View which stocks have been most impacted by Coronavirus.

The9's stock reverse split before market open on Wednesday, May 9th 2018. The 1-3 reverse split was announced on Tuesday, May 8th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 8th 2018. An investor that had 100 shares of The9 stock prior to the reverse split would have 33 shares after the split.

Media stories about NCTY stock have been trending negative on Sunday, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. The9 earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the technology company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next several days. View the latest news about The9.

The9 saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 21,600 shares, a decline of 63.3% from the May 31st total of 58,800 shares. Based on an average daily volume of 159,500 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the company's stock are sold short. View The9's Current Options Chain.

Some companies that are related to The9 include China Customer Relations Centers (CCRC), OmniComm Systems (OMCM), InnerWorkings (INWK), Marchex (MCHX), Research Solutions (RSSS), Heritage Global (HGBL), Exela Technologies (XELA), Solbright Group (SBRT), DynTek (DYNE), Dale Jarrett Racing Adventure (TVMD), Steel Connect (STCN), ALJ Regional (ALJJ), Weyland Tech (WEYL), BSQUARE (BSQR) and SPAR Group (SGRP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Anavex Life Sciences (AVXL), Gevo (GEVO), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Sangamo Therapeutics (SGMO), Verizon Communications (VZ), Advanced Micro Devices (AMD), AVEO Pharmaceuticals (AVEO) and Axsome Therapeutics (AXSM).

The9 trades on the NASDAQ under the ticker symbol "NCTY."

Shares of NCTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NCTY stock can currently be purchased for approximately $0.79.

The9 has a market capitalization of $24.18 million and generates $50,000.00 in revenue each year. The9 employs 105 workers across the globe.

The official website for The9 is www.the9.com.

The9's mailing address is BUILDING NO.3 690 BIBO ROAD ZHANG JIANG HI-TECH PARK, SHANGHAI F4, 201203. The technology company can be reached via phone at 86-21-5172-9999 or via email at [email protected]